|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitoring, Mitragynine, with Confirmation, Urine
Test Code39432
CPT Codes
80307
Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
If screening drug class result is equal to or greater than the cutoff, then confirmation testing will be performed at an additional charge (CPT code(s): 80323)
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
If screening drug class result is equal to or greater than the cutoff, then confirmation testing will be performed at an additional charge (CPT code(s): 80323)
Preferred Specimen
9 mL urine collected in a plastic leak-proof urine container
Minimum Volume
5 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Non-urine specimens • Preserved urine
Methodology
Screen: Immunoassay (IA) • Confirmation: Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues, Thurs, Sat; Report available: 4-7 days
Reference Range
| Mitragynine | <50 ng/mL |
| Mitragynine Confirmation | <2 ng/mL |
Clinical Significance
Monitoring of Mitragynine in urine, the results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
